Chemical Identity and Physical Properties

Diosmetin (CAS 520-34-3) is a naturally occurring flavone aglycone with the molecular formula C₁₆H₁₂O₆ and a molecular weight of approximately 300.26 g/mol. Its IUPAC name is 5,7-dihydroxy-2-(4-methoxyphenyl)-4H-chromen-4-one. Structurally, diosmetin is characterized by a 4′-methoxy group on ring B and hydroxyl groups at the 5 and 7 positions of the chromone backbone, distinguishing it from its glycoside form diosmin.

Diosmetin typically appears as a yellow crystalline powder. It has limited aqueous solubility, which is characteristic of many flavone aglycones. For laboratory use, stock solutions are most commonly prepared in dimethyl sulfoxide (DMSO) and subsequently diluted into aqueous culture media or buffers. Researchers should verify solubility and stability under their specific experimental conditions. Proper storage—typically at −20 °C, protected from light and moisture—is recommended to maintain compound integrity over time.

Biological Activities and Mechanisms of Action

Antioxidant Activity: Diosmetin exhibits potent free radical scavenging activity attributed to its phenolic hydroxyl groups. It has been shown in preclinical studies to reduce reactive oxygen species (ROS) levels and modulate antioxidant enzyme expression, including superoxide dismutase (SOD) and catalase. These properties make it a valuable tool compound for studying oxidative stress pathways.

Anti-inflammatory Effects: A substantial body of preclinical literature demonstrates that diosmetin can suppress pro-inflammatory signaling. Reported mechanisms include inhibition of NF-κB pathway activation and reduction in the expression of inflammatory mediators such as TNF-α, IL-6, and COX-2. These effects have been observed in macrophage cell models and various animal models of inflammation.

Anticancer Properties: Diosmetin has attracted considerable research interest for its ability to modulate cancer-relevant pathways. Preclinical studies report induction of apoptosis, inhibition of cell proliferation, and interference with cell cycle progression in various cancer cell lines. Reported molecular targets include MAPK/ERK signaling, PI3K/Akt pathways, and modulation of Bcl-2 family protein expression.

Other Activities: Additional areas of preclinical investigation include neuroprotection, hepatoprotection, cardioprotection, and antimicrobial activity. Research into diosmetin's capacity to modulate autophagy and its interactions with key kinases continues to expand its profile as a multipotent research tool compound.

Research Applications and Experimental Considerations

In Vitro Studies: Diosmetin is widely used in cell-based assays to investigate its effects on cell viability, apoptosis, ROS generation, and inflammatory cytokine production. Common experimental models include human cancer cell lines (e.g., HeLa, MCF-7, HepG2), macrophage lines (e.g., RAW 264.7), and primary cell cultures. Researchers should optimize concentration ranges empirically, as effective concentrations reported in the literature vary considerably by cell type and assay endpoint.

In Vivo Studies: Animal model studies have used diosmetin administered orally or intraperitoneally to evaluate its pharmacological effects in models of inflammation, oxidative injury, carcinogenesis, and metabolic disease. Bioavailability considerations are important, as the compound undergoes hepatic metabolism and may exhibit variable plasma exposure depending on formulation and route of administration.

Solubility and Formulation Tips: Due to its limited aqueous solubility, DMSO stock solutions (typically 10–50 mM) are recommended. When diluting into aqueous media, researchers should monitor for precipitation and consider using co-solvents or cyclodextrin complexation for enhanced bioavailability in cell culture or in vivo dosing. The final DMSO concentration in cell culture media should generally be kept below 0.1% (v/v) to avoid solvent cytotoxicity.

Purity and Quality: For reproducible results, high-purity diosmetin (≥98% by HPLC) is recommended. Aladdin Scientific's D137256 is intended for research use and is accompanied by a certificate of analysis detailing purity and physicochemical characteristics.

Comparison with Related Flavonoids

Diosmetin is structurally and pharmacologically related to several well-studied flavonoids, and understanding these relationships aids in experimental design and compound selection.

Diosmetin vs. Diosmin: Diosmin is the 7-O-rutinoside glycoside of diosmetin. Diosmin is clinically used as a venoactive drug and demonstrates improved water solubility relative to diosmetin. Upon ingestion, diosmin is hydrolyzed by intestinal microbiota to release diosmetin as the active aglycone. Researchers studying metabolite effects or aglycone-specific pharmacology typically prefer diosmetin directly.

Diosmetin vs. Luteolin: Luteolin (3′,4′,5,7-tetrahydroxyflavone) is the 4′-demethylated analog of diosmetin. Both compounds share anti-inflammatory and antioxidant activities, but their relative potencies and selectivity for specific targets can differ. The 4′-methoxy group of diosmetin affects membrane permeability and metabolic stability compared to luteolin's free hydroxyl.

Diosmetin vs. Apigenin: Apigenin (4′,5,7-trihydroxyflavone) lacks the 3′-hydroxyl group present in luteolin and shares the chromone scaffold with diosmetin. These structural differences influence receptor binding profiles and downstream signaling modulation.

Researchers are encouraged to run parallel experiments with structurally related analogs to delineate structure–activity relationships in their specific biological system.

Handling, Safety, and Storage Guidelines

General Handling: Diosmetin is supplied for research purposes only and is not approved for human therapeutic use. Standard laboratory safety practices should be followed when handling this compound, including the use of appropriate personal protective equipment (PPE) such as gloves, lab coat, and eye protection. Avoid inhalation of dust or aerosols.

Storage Conditions: Store diosmetin at −20 °C in a tightly sealed container, protected from light, heat, and moisture. Under these conditions, the compound is expected to be stable for an extended period. Always allow the container to equilibrate to room temperature before opening to prevent condensation and moisture-induced degradation.

Disposal: Dispose of diosmetin and solvent-containing waste in accordance with local institutional and regulatory guidelines for chemical waste disposal.

Regulatory Status: This product is intended solely for laboratory research use. It is not a drug, food additive, or clinical diagnostic reagent. Researchers are responsible for compliance with all applicable regulations governing the use and disposal of research chemicals in their jurisdiction.